Evidence map›Paper›PMID 32322810›Full record

ArticleEClinicalMedicine2020

Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study.

Theodoros Karantanos, Hannah Kaizer, Shruti Chaturvedi, Linda M S Resar, Alison R Moliterno

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EClinicalMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Theodoros KarantanosDepartment of Oncology, Hematologic malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Hannah KaizerOsler Internal Medicine Residency, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Shruti ChaturvediDivision of Adult Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Linda M S ResarDivision of Adult Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Alison R MoliternoDivision of Adult Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Funding

HMGA Chromatin Remodeling Proteins in Tumor Progression in Myeloproliferative Neoplasms (MPN)R01HL145780 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MOLITERNO, ALISON R, RESAR, LINDA M S · 2018 to 2021
$1.9M
NHLBI NIH HHS R01 HL145780
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32322810
PMCPMC7167502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.